nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ORM1—Vemurafenib—melanoma	0.123	0.287	CbGbCtD
Amitriptyline—ALB—melanoma	0.108	0.512	CbGaD
Amitriptyline—ABCB1—melanoma	0.103	0.488	CbGaD
Amitriptyline—ALB—Vemurafenib—melanoma	0.052	0.121	CbGbCtD
Amitriptyline—CYP2E1—Dacarbazine—melanoma	0.0412	0.0958	CbGbCtD
Amitriptyline—CYP1A2—Carmustine—melanoma	0.0393	0.0915	CbGbCtD
Amitriptyline—CYP1A2—Vemurafenib—melanoma	0.0311	0.0723	CbGbCtD
Amitriptyline—CYP3A4—Temozolomide—melanoma	0.0297	0.0692	CbGbCtD
Amitriptyline—CYP2D6—Vemurafenib—melanoma	0.0256	0.0596	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—melanoma	0.0238	0.0554	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—melanoma	0.0181	0.042	CbGbCtD
Amitriptyline—CYP3A4—Vemurafenib—melanoma	0.0163	0.0379	CbGbCtD
Amitriptyline—CYP3A5—Docetaxel—melanoma	0.0143	0.0333	CbGbCtD
Amitriptyline—HTR1D—meninx—melanoma	0.0104	0.176	CbGeAlD
Amitriptyline—ABCB1—Docetaxel—melanoma	0.00933	0.0217	CbGbCtD
Amitriptyline—Electrocardiogram QT corrected interval prolonged—Vemurafenib—melanoma	0.00604	0.0683	CcSEcCtD
Amitriptyline—CYP3A4—Docetaxel—melanoma	0.00559	0.013	CbGbCtD
Amitriptyline—NTRK2—neck—melanoma	0.00295	0.0499	CbGeAlD
Amitriptyline—CHRM5—skin epidermis—melanoma	0.00264	0.0447	CbGeAlD
Amitriptyline—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00253	0.0287	CcSEcCtD
Amitriptyline—NTRK2—eye—melanoma	0.00219	0.0371	CbGeAlD
Amitriptyline—NTRK2—retina—melanoma	0.00217	0.0368	CbGeAlD
Amitriptyline—Tongue discolouration—Temozolomide—melanoma	0.00172	0.0195	CcSEcCtD
Amitriptyline—Olopatadine—S100B—melanoma	0.00162	0.561	CrCbGaD
Amitriptyline—KCNQ2—eye—melanoma	0.00153	0.0259	CbGeAlD
Amitriptyline—Cerebration impaired—Temozolomide—melanoma	0.00141	0.016	CcSEcCtD
Amitriptyline—KCNA1—retina—melanoma	0.00126	0.0213	CbGeAlD
Amitriptyline—NTRK2—head—melanoma	0.00124	0.0211	CbGeAlD
Amitriptyline—HTR2A—hindlimb—melanoma	0.00123	0.0208	CbGeAlD
Amitriptyline—HTR1B—blood vessel—melanoma	0.00122	0.0206	CbGeAlD
Amitriptyline—Arthritis—Vemurafenib—melanoma	0.00121	0.0137	CcSEcCtD
Amitriptyline—HTR1D—blood vessel—melanoma	0.00118	0.02	CbGeAlD
Amitriptyline—Extrapyramidal disorder—Temozolomide—melanoma	0.0011	0.0125	CcSEcCtD
Amitriptyline—HTR2A—appendage—melanoma	0.00105	0.0178	CbGeAlD
Amitriptyline—HTR7—endothelium—melanoma	0.00102	0.0173	CbGeAlD
Amitriptyline—Eosinophilia—Vemurafenib—melanoma	0.00101	0.0114	CcSEcCtD
Amitriptyline—Disturbance in attention—Temozolomide—melanoma	0.000959	0.0109	CcSEcCtD
Amitriptyline—KCNQ3—head—melanoma	0.000943	0.016	CbGeAlD
Amitriptyline—HTR7—blood vessel—melanoma	0.00094	0.0159	CbGeAlD
Amitriptyline—CHRM5—eye—melanoma	0.00094	0.0159	CbGeAlD
Amitriptyline—Neuropathy peripheral—Vemurafenib—melanoma	0.000892	0.0101	CcSEcCtD
Amitriptyline—Coordination abnormal—Carmustine—melanoma	0.000876	0.00991	CcSEcCtD
Amitriptyline—NTRK2—lymph node—melanoma	0.000871	0.0148	CbGeAlD
Amitriptyline—KCNQ2—head—melanoma	0.000868	0.0147	CbGeAlD
Amitriptyline—HRH2—skin of body—melanoma	0.000856	0.0145	CbGeAlD
Amitriptyline—Coordination abnormal—Temozolomide—melanoma	0.000846	0.00957	CcSEcCtD
Amitriptyline—KCND2—head—melanoma	0.000822	0.0139	CbGeAlD
Amitriptyline—CHRM5—skin of body—melanoma	0.000818	0.0138	CbGeAlD
Amitriptyline—Disorientation—Bleomycin—melanoma	0.000799	0.00904	CcSEcCtD
Amitriptyline—Coma—Carmustine—melanoma	0.000786	0.00889	CcSEcCtD
Amitriptyline—Gynaecomastia—Carmustine—melanoma	0.000769	0.0087	CcSEcCtD
Amitriptyline—Mental disability—Carmustine—melanoma	0.000746	0.00844	CcSEcCtD
Amitriptyline—Hepatic failure—Dactinomycin—melanoma	0.000742	0.0084	CcSEcCtD
Amitriptyline—Arthritis—Bleomycin—melanoma	0.000736	0.00832	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Bleomycin—melanoma	0.00073	0.00826	CcSEcCtD
Amitriptyline—Alopecia—Vemurafenib—melanoma	0.000722	0.00816	CcSEcCtD
Amitriptyline—Mental disability—Temozolomide—melanoma	0.000721	0.00816	CcSEcCtD
Amitriptyline—KCNA1—head—melanoma	0.00072	0.0122	CbGeAlD
Amitriptyline—KCND3—head—melanoma	0.000717	0.0121	CbGeAlD
Amitriptyline—Dysgeusia—Vemurafenib—melanoma	0.000696	0.00787	CcSEcCtD
Amitriptyline—CHRM4—head—melanoma	0.000683	0.0116	CbGeAlD
Amitriptyline—Ageusia—Docetaxel—melanoma	0.000682	0.00772	CcSEcCtD
Amitriptyline—Vascular purpura—Temozolomide—melanoma	0.000674	0.00763	CcSEcCtD
Amitriptyline—HTR7—neck—melanoma	0.000672	0.0114	CbGeAlD
Amitriptyline—Hepatic failure—Temozolomide—melanoma	0.000671	0.00759	CcSEcCtD
Amitriptyline—HTR2A—endothelium—melanoma	0.000636	0.0108	CbGeAlD
Amitriptyline—DRD3—head—melanoma	0.000635	0.0107	CbGeAlD
Amitriptyline—HTR1D—eye—melanoma	0.000628	0.0106	CbGeAlD
Amitriptyline—Purpura—Temozolomide—melanoma	0.000626	0.00708	CcSEcCtD
Amitriptyline—HTR6—head—melanoma	0.000611	0.0103	CbGeAlD
Amitriptyline—OPRD1—head—melanoma	0.00059	0.00999	CbGeAlD
Amitriptyline—Pancytopenia—Bleomycin—melanoma	0.000587	0.00664	CcSEcCtD
Amitriptyline—Ataxia—Carmustine—melanoma	0.000587	0.00664	CcSEcCtD
Amitriptyline—HTR2A—blood vessel—melanoma	0.000586	0.00992	CbGeAlD
Amitriptyline—SIGMAR1—eye—melanoma	0.000585	0.00991	CbGeAlD
Amitriptyline—Ataxia—Temozolomide—melanoma	0.000567	0.00642	CcSEcCtD
Amitriptyline—OPRK1—head—melanoma	0.000566	0.00958	CbGeAlD
Amitriptyline—HRH2—head—melanoma	0.000559	0.00946	CbGeAlD
Amitriptyline—Pancytopenia—Dactinomycin—melanoma	0.000547	0.00619	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Bleomycin—melanoma	0.000543	0.00615	CcSEcCtD
Amitriptyline—Hypotension—Vemurafenib—melanoma	0.000542	0.00613	CcSEcCtD
Amitriptyline—Myocardial infarction—Bleomycin—melanoma	0.00054	0.00611	CcSEcCtD
Amitriptyline—Stomatitis—Bleomycin—melanoma	0.000537	0.00608	CcSEcCtD
Amitriptyline—CHRM5—head—melanoma	0.000534	0.00903	CbGeAlD
Amitriptyline—Pancytopenia—Carmustine—melanoma	0.000512	0.0058	CcSEcCtD
Amitriptyline—Sweating increased—Temozolomide—melanoma	0.000508	0.00575	CcSEcCtD
Amitriptyline—Decreased appetite—Vemurafenib—melanoma	0.000504	0.00571	CcSEcCtD
Amitriptyline—KCND3—lymph node—melanoma	0.000502	0.00849	CbGeAlD
Amitriptyline—Stomatitis—Dactinomycin—melanoma	0.000501	0.00567	CcSEcCtD
Amitriptyline—Fatigue—Vemurafenib—melanoma	0.0005	0.00566	CcSEcCtD
Amitriptyline—Constipation—Vemurafenib—melanoma	0.000496	0.00561	CcSEcCtD
Amitriptyline—Pancytopenia—Temozolomide—melanoma	0.000495	0.0056	CcSEcCtD
Amitriptyline—Hypoaesthesia—Bleomycin—melanoma	0.000492	0.00557	CcSEcCtD
Amitriptyline—ADRA1B—head—melanoma	0.000488	0.00825	CbGeAlD
Amitriptyline—Pollakiuria—Temozolomide—melanoma	0.000482	0.00545	CcSEcCtD
Amitriptyline—Erectile dysfunction—Temozolomide—melanoma	0.00048	0.00543	CcSEcCtD
Amitriptyline—Agranulocytosis—Dactinomycin—melanoma	0.00048	0.00543	CcSEcCtD
Amitriptyline—ADRA1D—head—melanoma	0.000477	0.00807	CbGeAlD
Amitriptyline—Weight increased—Temozolomide—melanoma	0.000475	0.00537	CcSEcCtD
Amitriptyline—DRD2—eye—melanoma	0.000473	0.00801	CbGeAlD
Amitriptyline—Neuropathy peripheral—Carmustine—melanoma	0.000472	0.00533	CcSEcCtD
Amitriptyline—Stomatitis—Carmustine—melanoma	0.000469	0.0053	CcSEcCtD
Amitriptyline—DRD2—retina—melanoma	0.000469	0.00793	CbGeAlD
Amitriptyline—SIGMAR1—mammalian vulva—melanoma	0.000465	0.00786	CbGeAlD
Amitriptyline—Hepatitis—Dactinomycin—melanoma	0.000461	0.00522	CcSEcCtD
Amitriptyline—Body temperature increased—Vemurafenib—melanoma	0.000459	0.00519	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Temozolomide—melanoma	0.000456	0.00516	CcSEcCtD
Amitriptyline—Stomatitis—Temozolomide—melanoma	0.000453	0.00513	CcSEcCtD
Amitriptyline—Hepatic failure—Docetaxel—melanoma	0.000446	0.00505	CcSEcCtD
Amitriptyline—Alopecia—Bleomycin—melanoma	0.000437	0.00495	CcSEcCtD
Amitriptyline—Hallucination—Carmustine—melanoma	0.00043	0.00486	CcSEcCtD
Amitriptyline—Hypoaesthesia—Carmustine—melanoma	0.00043	0.00486	CcSEcCtD
Amitriptyline—HTR2A—neck—melanoma	0.000419	0.0071	CbGeAlD
Amitriptyline—Hepatitis—Temozolomide—melanoma	0.000417	0.00472	CcSEcCtD
Amitriptyline—Asthenia—Vemurafenib—melanoma	0.000416	0.00471	CcSEcCtD
Amitriptyline—Hallucination—Temozolomide—melanoma	0.000415	0.0047	CcSEcCtD
Amitriptyline—Hypoaesthesia—Temozolomide—melanoma	0.000415	0.0047	CcSEcCtD
Amitriptyline—Pruritus—Vemurafenib—melanoma	0.00041	0.00464	CcSEcCtD
Amitriptyline—Alopecia—Dactinomycin—melanoma	0.000408	0.00461	CcSEcCtD
Amitriptyline—OPRM1—head—melanoma	0.000402	0.00681	CbGeAlD
Amitriptyline—Ill-defined disorder—Bleomycin—melanoma	0.0004	0.00452	CcSEcCtD
Amitriptyline—Diarrhoea—Vemurafenib—melanoma	0.000397	0.00449	CcSEcCtD
Amitriptyline—HRH2—lymph node—melanoma	0.000391	0.00662	CbGeAlD
Amitriptyline—Tinnitus—Temozolomide—melanoma	0.000389	0.0044	CcSEcCtD
Amitriptyline—Malaise—Bleomycin—melanoma	0.000388	0.00439	CcSEcCtD
Amitriptyline—Arrhythmia—Carmustine—melanoma	0.000386	0.00436	CcSEcCtD
Amitriptyline—Leukopenia—Bleomycin—melanoma	0.000386	0.00436	CcSEcCtD
Amitriptyline—ABCB1—blood vessel—melanoma	0.000384	0.0065	CbGeAlD
Amitriptyline—Dizziness—Vemurafenib—melanoma	0.000384	0.00434	CcSEcCtD
Amitriptyline—Alopecia—Carmustine—melanoma	0.000382	0.00432	CcSEcCtD
Amitriptyline—Ataxia—Docetaxel—melanoma	0.000377	0.00427	CcSEcCtD
Amitriptyline—HRH1—eye—melanoma	0.000374	0.00632	CbGeAlD
Amitriptyline—Ill-defined disorder—Dactinomycin—melanoma	0.000373	0.00422	CcSEcCtD
Amitriptyline—Vomiting—Vemurafenib—melanoma	0.000369	0.00417	CcSEcCtD
Amitriptyline—Alopecia—Temozolomide—melanoma	0.000369	0.00417	CcSEcCtD
Amitriptyline—HTR1B—head—melanoma	0.000368	0.00623	CbGeAlD
Amitriptyline—Orthostatic hypotension—Docetaxel—melanoma	0.000366	0.00414	CcSEcCtD
Amitriptyline—CHRM2—head—melanoma	0.000366	0.0062	CbGeAlD
Amitriptyline—Rash—Vemurafenib—melanoma	0.000366	0.00414	CcSEcCtD
Amitriptyline—Dermatitis—Vemurafenib—melanoma	0.000365	0.00413	CcSEcCtD
Amitriptyline—Headache—Vemurafenib—melanoma	0.000363	0.00411	CcSEcCtD
Amitriptyline—Discomfort—Bleomycin—melanoma	0.000362	0.0041	CcSEcCtD
Amitriptyline—Malaise—Dactinomycin—melanoma	0.000362	0.0041	CcSEcCtD
Amitriptyline—Leukopenia—Dactinomycin—melanoma	0.00036	0.00407	CcSEcCtD
Amitriptyline—HTR1D—head—melanoma	0.000356	0.00603	CbGeAlD
Amitriptyline—Dysgeusia—Temozolomide—melanoma	0.000356	0.00402	CcSEcCtD
Amitriptyline—Confusional state—Bleomycin—melanoma	0.000354	0.00401	CcSEcCtD
Amitriptyline—Vision blurred—Carmustine—melanoma	0.000354	0.00401	CcSEcCtD
Amitriptyline—HTR2C—head—melanoma	0.000353	0.00598	CbGeAlD
Amitriptyline—Tremor—Carmustine—melanoma	0.000352	0.00398	CcSEcCtD
Amitriptyline—Oedema—Bleomycin—melanoma	0.000352	0.00398	CcSEcCtD
Amitriptyline—Agitation—Carmustine—melanoma	0.000345	0.00391	CcSEcCtD
Amitriptyline—Nausea—Vemurafenib—melanoma	0.000345	0.0039	CcSEcCtD
Amitriptyline—Thrombocytopenia—Bleomycin—melanoma	0.000344	0.00389	CcSEcCtD
Amitriptyline—Vision blurred—Temozolomide—melanoma	0.000342	0.00387	CcSEcCtD
Amitriptyline—Tremor—Temozolomide—melanoma	0.00034	0.00385	CcSEcCtD
Amitriptyline—Discomfort—Dactinomycin—melanoma	0.000338	0.00382	CcSEcCtD
Amitriptyline—Ill-defined disorder—Temozolomide—melanoma	0.000337	0.00381	CcSEcCtD
Amitriptyline—Leukopenia—Carmustine—melanoma	0.000337	0.00381	CcSEcCtD
Amitriptyline—Anorexia—Bleomycin—melanoma	0.000335	0.00379	CcSEcCtD
Amitriptyline—SLC6A4—head—melanoma	0.000335	0.00567	CbGeAlD
Amitriptyline—Agitation—Temozolomide—melanoma	0.000334	0.00378	CcSEcCtD
Amitriptyline—CHRM1—head—melanoma	0.000333	0.00564	CbGeAlD
Amitriptyline—CYP2B6—skin of body—melanoma	0.000333	0.00563	CbGeAlD
Amitriptyline—Pancytopenia—Docetaxel—melanoma	0.000329	0.00372	CcSEcCtD
Amitriptyline—Hypotension—Bleomycin—melanoma	0.000328	0.00372	CcSEcCtD
Amitriptyline—Oedema—Dactinomycin—melanoma	0.000328	0.00371	CcSEcCtD
Amitriptyline—Malaise—Temozolomide—melanoma	0.000328	0.00371	CcSEcCtD
Amitriptyline—Convulsion—Carmustine—melanoma	0.000326	0.00368	CcSEcCtD
Amitriptyline—Leukopenia—Temozolomide—melanoma	0.000325	0.00368	CcSEcCtD
Amitriptyline—Hypertension—Carmustine—melanoma	0.000325	0.00367	CcSEcCtD
Amitriptyline—Palpitations—Temozolomide—melanoma	0.000321	0.00363	CcSEcCtD
Amitriptyline—Thrombocytopenia—Dactinomycin—melanoma	0.000321	0.00363	CcSEcCtD
Amitriptyline—Anxiety—Carmustine—melanoma	0.000319	0.00361	CcSEcCtD
Amitriptyline—Paraesthesia—Bleomycin—melanoma	0.000316	0.00357	CcSEcCtD
Amitriptyline—Weight increased—Docetaxel—melanoma	0.000316	0.00357	CcSEcCtD
Amitriptyline—Convulsion—Temozolomide—melanoma	0.000315	0.00356	CcSEcCtD
Amitriptyline—Hypertension—Temozolomide—melanoma	0.000314	0.00355	CcSEcCtD
Amitriptyline—Anorexia—Dactinomycin—melanoma	0.000312	0.00353	CcSEcCtD
Amitriptyline—HTR2A—eye—melanoma	0.000312	0.00528	CbGeAlD
Amitriptyline—Confusional state—Carmustine—melanoma	0.000309	0.0035	CcSEcCtD
Amitriptyline—HTR2A—retina—melanoma	0.000309	0.00523	CbGeAlD
Amitriptyline—Anxiety—Temozolomide—melanoma	0.000308	0.00349	CcSEcCtD
Amitriptyline—Oedema—Carmustine—melanoma	0.000307	0.00347	CcSEcCtD
Amitriptyline—Discomfort—Temozolomide—melanoma	0.000306	0.00346	CcSEcCtD
Amitriptyline—Decreased appetite—Bleomycin—melanoma	0.000306	0.00346	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Docetaxel—melanoma	0.000305	0.00345	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Docetaxel—melanoma	0.000303	0.00343	CcSEcCtD
Amitriptyline—Myocardial infarction—Docetaxel—melanoma	0.000303	0.00343	CcSEcCtD
Amitriptyline—Dry mouth—Temozolomide—melanoma	0.000302	0.00342	CcSEcCtD
Amitriptyline—Stomatitis—Docetaxel—melanoma	0.000301	0.00341	CcSEcCtD
Amitriptyline—Jaundice—Docetaxel—melanoma	0.000301	0.00341	CcSEcCtD
Amitriptyline—Thrombocytopenia—Carmustine—melanoma	0.0003	0.0034	CcSEcCtD
Amitriptyline—Tachycardia—Carmustine—melanoma	0.000299	0.00339	CcSEcCtD
Amitriptyline—Confusional state—Temozolomide—melanoma	0.000299	0.00338	CcSEcCtD
Amitriptyline—CHRM3—head—melanoma	0.000298	0.00505	CbGeAlD
Amitriptyline—HTR1A—head—melanoma	0.000297	0.00503	CbGeAlD
Amitriptyline—Oedema—Temozolomide—melanoma	0.000297	0.00335	CcSEcCtD
Amitriptyline—HRH1—mammalian vulva—melanoma	0.000296	0.00502	CbGeAlD
Amitriptyline—SLC6A2—head—melanoma	0.000295	0.00499	CbGeAlD
Amitriptyline—Anorexia—Carmustine—melanoma	0.000292	0.00331	CcSEcCtD
Amitriptyline—ADRA2A—mammalian vulva—melanoma	0.000291	0.00493	CbGeAlD
Amitriptyline—Thrombocytopenia—Temozolomide—melanoma	0.00029	0.00328	CcSEcCtD
Amitriptyline—Feeling abnormal—Bleomycin—melanoma	0.00029	0.00328	CcSEcCtD
Amitriptyline—Agranulocytosis—Docetaxel—melanoma	0.000289	0.00326	CcSEcCtD
Amitriptyline—Orphenadrine—SCN10A—melanoma	0.000288	0.0996	CrCbGaD
Amitriptyline—Hypotension—Carmustine—melanoma	0.000287	0.00324	CcSEcCtD
Amitriptyline—Hyperhidrosis—Temozolomide—melanoma	0.000287	0.00324	CcSEcCtD
Amitriptyline—Decreased appetite—Dactinomycin—melanoma	0.000285	0.00322	CcSEcCtD
Amitriptyline—HTR7—head—melanoma	0.000284	0.00481	CbGeAlD
Amitriptyline—Fatigue—Dactinomycin—melanoma	0.000283	0.0032	CcSEcCtD
Amitriptyline—Anorexia—Temozolomide—melanoma	0.000283	0.0032	CcSEcCtD
Amitriptyline—Urticaria—Bleomycin—melanoma	0.000279	0.00316	CcSEcCtD
Amitriptyline—Body temperature increased—Bleomycin—melanoma	0.000278	0.00314	CcSEcCtD
Amitriptyline—Hepatitis—Docetaxel—melanoma	0.000278	0.00314	CcSEcCtD
Amitriptyline—Insomnia—Carmustine—melanoma	0.000278	0.00314	CcSEcCtD
Amitriptyline—Hypoaesthesia—Docetaxel—melanoma	0.000276	0.00312	CcSEcCtD
Amitriptyline—Paraesthesia—Carmustine—melanoma	0.000276	0.00312	CcSEcCtD
Amitriptyline—ORM1—lymph node—melanoma	0.000275	0.00466	CbGeAlD
Amitriptyline—ADRA1A—head—melanoma	0.000274	0.00464	CbGeAlD
Amitriptyline—Somnolence—Carmustine—melanoma	0.000273	0.00309	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—melanoma	0.00027	0.00306	CcSEcCtD
Amitriptyline—DRD2—head—melanoma	0.000268	0.00455	CbGeAlD
Amitriptyline—Insomnia—Temozolomide—melanoma	0.000268	0.00303	CcSEcCtD
Amitriptyline—Decreased appetite—Carmustine—melanoma	0.000267	0.00302	CcSEcCtD
Amitriptyline—Paraesthesia—Temozolomide—melanoma	0.000266	0.00301	CcSEcCtD
Amitriptyline—Somnolence—Temozolomide—melanoma	0.000264	0.00298	CcSEcCtD
Amitriptyline—Constipation—Carmustine—melanoma	0.000262	0.00297	CcSEcCtD
Amitriptyline—Dyspepsia—Temozolomide—melanoma	0.000261	0.00295	CcSEcCtD
Amitriptyline—Body temperature increased—Dactinomycin—melanoma	0.000259	0.00293	CcSEcCtD
Amitriptyline—Decreased appetite—Temozolomide—melanoma	0.000258	0.00292	CcSEcCtD
Amitriptyline—Fatigue—Temozolomide—melanoma	0.000256	0.00289	CcSEcCtD
Amitriptyline—Constipation—Temozolomide—melanoma	0.000254	0.00287	CcSEcCtD
Amitriptyline—Feeling abnormal—Carmustine—melanoma	0.000253	0.00286	CcSEcCtD
Amitriptyline—Asthenia—Bleomycin—melanoma	0.000252	0.00285	CcSEcCtD
Amitriptyline—Pruritus—Bleomycin—melanoma	0.000249	0.00281	CcSEcCtD
Amitriptyline—Arrhythmia—Docetaxel—melanoma	0.000248	0.0028	CcSEcCtD
Amitriptyline—Alopecia—Docetaxel—melanoma	0.000245	0.00277	CcSEcCtD
Amitriptyline—Feeling abnormal—Temozolomide—melanoma	0.000244	0.00276	CcSEcCtD
Amitriptyline—Body temperature increased—Carmustine—melanoma	0.000243	0.00274	CcSEcCtD
Amitriptyline—ALB—lymph node—melanoma	0.000241	0.00408	CbGeAlD
Amitriptyline—Dysgeusia—Docetaxel—melanoma	0.000237	0.00268	CcSEcCtD
Amitriptyline—Urticaria—Temozolomide—melanoma	0.000236	0.00266	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—melanoma	0.000235	0.00266	CcSEcCtD
Amitriptyline—Body temperature increased—Temozolomide—melanoma	0.000234	0.00265	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—melanoma	0.000233	0.00394	CbGeAlD
Amitriptyline—Diarrhoea—Dactinomycin—melanoma	0.000224	0.00254	CcSEcCtD
Amitriptyline—Vomiting—Bleomycin—melanoma	0.000223	0.00253	CcSEcCtD
Amitriptyline—Rash—Bleomycin—melanoma	0.000222	0.00251	CcSEcCtD
Amitriptyline—Dermatitis—Bleomycin—melanoma	0.000221	0.0025	CcSEcCtD
Amitriptyline—Asthenia—Carmustine—melanoma	0.00022	0.00249	CcSEcCtD
Amitriptyline—CYP2B6—head—melanoma	0.000217	0.00368	CbGeAlD
Amitriptyline—Syncope—Docetaxel—melanoma	0.000217	0.00245	CcSEcCtD
Amitriptyline—Leukopenia—Docetaxel—melanoma	0.000216	0.00245	CcSEcCtD
Amitriptyline—Palpitations—Docetaxel—melanoma	0.000214	0.00242	CcSEcCtD
Amitriptyline—Asthenia—Temozolomide—melanoma	0.000213	0.00241	CcSEcCtD
Amitriptyline—Loss of consciousness—Docetaxel—melanoma	0.000212	0.0024	CcSEcCtD
Amitriptyline—HRH1—head—melanoma	0.000212	0.00359	CbGeAlD
Amitriptyline—Diarrhoea—Carmustine—melanoma	0.00021	0.00237	CcSEcCtD
Amitriptyline—Pruritus—Temozolomide—melanoma	0.00021	0.00237	CcSEcCtD
Amitriptyline—Convulsion—Docetaxel—melanoma	0.000209	0.00237	CcSEcCtD
Amitriptyline—Nausea—Bleomycin—melanoma	0.000209	0.00236	CcSEcCtD
Amitriptyline—Hypertension—Docetaxel—melanoma	0.000209	0.00236	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—melanoma	0.000208	0.00236	CcSEcCtD
Amitriptyline—ADRA2A—head—melanoma	0.000208	0.00353	CbGeAlD
Amitriptyline—Rash—Dactinomycin—melanoma	0.000207	0.00234	CcSEcCtD
Amitriptyline—SLC6A2—lymph node—melanoma	0.000206	0.00349	CbGeAlD
Amitriptyline—CYP2E1—head—melanoma	0.000204	0.00345	CbGeAlD
Amitriptyline—Dizziness—Carmustine—melanoma	0.000203	0.0023	CcSEcCtD
Amitriptyline—Diarrhoea—Temozolomide—melanoma	0.000203	0.00229	CcSEcCtD
Amitriptyline—ABCB1—retina—melanoma	0.000203	0.00343	CbGeAlD
Amitriptyline—Dry mouth—Docetaxel—melanoma	0.000201	0.00228	CcSEcCtD
Amitriptyline—Confusional state—Docetaxel—melanoma	0.000199	0.00225	CcSEcCtD
Amitriptyline—Oedema—Docetaxel—melanoma	0.000197	0.00223	CcSEcCtD
Amitriptyline—Dizziness—Temozolomide—melanoma	0.000196	0.00222	CcSEcCtD
Amitriptyline—Vomiting—Carmustine—melanoma	0.000195	0.00221	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—melanoma	0.000195	0.0022	CcSEcCtD
Amitriptyline—Shock—Docetaxel—melanoma	0.000194	0.00219	CcSEcCtD
Amitriptyline—Rash—Carmustine—melanoma	0.000193	0.00219	CcSEcCtD
Amitriptyline—Dermatitis—Carmustine—melanoma	0.000193	0.00219	CcSEcCtD
Amitriptyline—Thrombocytopenia—Docetaxel—melanoma	0.000193	0.00218	CcSEcCtD
Amitriptyline—Tachycardia—Docetaxel—melanoma	0.000192	0.00218	CcSEcCtD
Amitriptyline—Headache—Carmustine—melanoma	0.000192	0.00217	CcSEcCtD
Amitriptyline—Vomiting—Temozolomide—melanoma	0.000189	0.00213	CcSEcCtD
Amitriptyline—Anorexia—Docetaxel—melanoma	0.000188	0.00213	CcSEcCtD
Amitriptyline—Rash—Temozolomide—melanoma	0.000187	0.00211	CcSEcCtD
Amitriptyline—Dermatitis—Temozolomide—melanoma	0.000187	0.00211	CcSEcCtD
Amitriptyline—Headache—Temozolomide—melanoma	0.000186	0.0021	CcSEcCtD
Amitriptyline—Hypotension—Docetaxel—melanoma	0.000184	0.00208	CcSEcCtD
Amitriptyline—Nausea—Carmustine—melanoma	0.000182	0.00206	CcSEcCtD
Amitriptyline—Insomnia—Docetaxel—melanoma	0.000178	0.00202	CcSEcCtD
Amitriptyline—HTR2A—head—melanoma	0.000177	0.003	CbGeAlD
Amitriptyline—Paraesthesia—Docetaxel—melanoma	0.000177	0.002	CcSEcCtD
Amitriptyline—Nausea—Temozolomide—melanoma	0.000176	0.00199	CcSEcCtD
Amitriptyline—Somnolence—Docetaxel—melanoma	0.000175	0.00198	CcSEcCtD
Amitriptyline—Dyspepsia—Docetaxel—melanoma	0.000174	0.00196	CcSEcCtD
Amitriptyline—Decreased appetite—Docetaxel—melanoma	0.000171	0.00194	CcSEcCtD
Amitriptyline—Fatigue—Docetaxel—melanoma	0.00017	0.00192	CcSEcCtD
Amitriptyline—Constipation—Docetaxel—melanoma	0.000169	0.00191	CcSEcCtD
Amitriptyline—Feeling abnormal—Docetaxel—melanoma	0.000162	0.00184	CcSEcCtD
Amitriptyline—ABCB1—mammalian vulva—melanoma	0.000162	0.00275	CbGeAlD
Amitriptyline—CYP2D6—head—melanoma	0.000161	0.00273	CbGeAlD
Amitriptyline—Body temperature increased—Docetaxel—melanoma	0.000156	0.00176	CcSEcCtD
Amitriptyline—HRH1—lymph node—melanoma	0.000148	0.00251	CbGeAlD
Amitriptyline—ADRA2A—lymph node—melanoma	0.000146	0.00247	CbGeAlD
Amitriptyline—Asthenia—Docetaxel—melanoma	0.000141	0.0016	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—melanoma	0.00014	0.0483	CrCbGaD
Amitriptyline—Pruritus—Docetaxel—melanoma	0.00014	0.00158	CcSEcCtD
Amitriptyline—Oxcarbazepine—ALB—melanoma	0.000135	0.0467	CrCbGaD
Amitriptyline—Diarrhoea—Docetaxel—melanoma	0.000135	0.00153	CcSEcCtD
Amitriptyline—Dizziness—Docetaxel—melanoma	0.00013	0.00147	CcSEcCtD
Amitriptyline—Vomiting—Docetaxel—melanoma	0.000125	0.00142	CcSEcCtD
Amitriptyline—Rash—Docetaxel—melanoma	0.000124	0.00141	CcSEcCtD
Amitriptyline—Dermatitis—Docetaxel—melanoma	0.000124	0.00141	CcSEcCtD
Amitriptyline—Headache—Docetaxel—melanoma	0.000124	0.0014	CcSEcCtD
Amitriptyline—Nausea—Docetaxel—melanoma	0.000117	0.00132	CcSEcCtD
Amitriptyline—ABCB1—head—melanoma	0.000116	0.00196	CbGeAlD
Amitriptyline—Thiothixene—ALB—melanoma	9.81e-05	0.0339	CrCbGaD
Amitriptyline—ABCB1—lymph node—melanoma	8.13e-05	0.00138	CbGeAlD
Amitriptyline—Clomipramine—ALB—melanoma	7.75e-05	0.0268	CrCbGaD
Amitriptyline—Nortriptyline—ALB—melanoma	7.58e-05	0.0262	CrCbGaD
Amitriptyline—Clomipramine—ABCB1—melanoma	7.4e-05	0.0256	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—melanoma	7.37e-05	0.0255	CrCbGaD
Amitriptyline—Trimipramine—ABCB1—melanoma	6.81e-05	0.0235	CrCbGaD
Amitriptyline—Promethazine—ABCB1—melanoma	6.55e-05	0.0227	CrCbGaD
Amitriptyline—Doxepin—ABCB1—melanoma	6.49e-05	0.0224	CrCbGaD
Amitriptyline—Desipramine—ABCB1—melanoma	5.95e-05	0.0206	CrCbGaD
Amitriptyline—Imipramine—ABCB1—melanoma	5.05e-05	0.0175	CrCbGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.71e-06	8.17e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK3—melanoma	1.71e-06	8.17e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—melanoma	1.71e-06	8.17e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—melanoma	1.71e-06	8.16e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1A—melanoma	1.71e-06	8.15e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—melanoma	1.7e-06	8.13e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—melanoma	1.7e-06	8.12e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NFKB1—melanoma	1.7e-06	8.12e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—melanoma	1.7e-06	8.11e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—melanoma	1.7e-06	8.1e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—melanoma	1.7e-06	8.1e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NFKB1—melanoma	1.7e-06	8.09e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—melanoma	1.69e-06	8.09e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—melanoma	1.69e-06	8.07e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—melanoma	1.69e-06	8.06e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—melanoma	1.69e-06	8.05e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—melanoma	1.68e-06	8.04e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—melanoma	1.68e-06	8.03e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—melanoma	1.68e-06	8.03e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—melanoma	1.68e-06	8.01e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—melanoma	1.68e-06	8e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—melanoma	1.67e-06	7.99e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—melanoma	1.67e-06	7.99e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—melanoma	1.67e-06	7.96e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—melanoma	1.66e-06	7.95e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—melanoma	1.66e-06	7.93e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.66e-06	7.9e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—melanoma	1.65e-06	7.88e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—melanoma	1.65e-06	7.86e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—melanoma	1.64e-06	7.83e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK3—melanoma	1.64e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—melanoma	1.64e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK1—melanoma	1.64e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—melanoma	1.64e-06	7.81e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—melanoma	1.63e-06	7.78e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—melanoma	1.63e-06	7.78e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK1—melanoma	1.63e-06	7.78e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—melanoma	1.63e-06	7.77e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—melanoma	1.62e-06	7.75e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—melanoma	1.62e-06	7.75e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—melanoma	1.62e-06	7.72e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—melanoma	1.6e-06	7.66e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—melanoma	1.6e-06	7.65e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—melanoma	1.6e-06	7.65e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—melanoma	1.6e-06	7.62e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—melanoma	1.59e-06	7.61e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—melanoma	1.59e-06	7.6e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—melanoma	1.59e-06	7.6e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—melanoma	1.59e-06	7.6e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—melanoma	1.59e-06	7.57e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—melanoma	1.58e-06	7.56e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—melanoma	1.58e-06	7.55e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—melanoma	1.58e-06	7.53e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—melanoma	1.58e-06	7.53e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—melanoma	1.58e-06	7.53e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—melanoma	1.58e-06	7.53e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NFKB1—melanoma	1.58e-06	7.52e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—melanoma	1.57e-06	7.5e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—melanoma	1.57e-06	7.49e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—melanoma	1.57e-06	7.49e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—melanoma	1.57e-06	7.48e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—melanoma	1.56e-06	7.46e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK1—melanoma	1.56e-06	7.44e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—melanoma	1.56e-06	7.44e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—melanoma	1.56e-06	7.44e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—melanoma	1.56e-06	7.43e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—melanoma	1.56e-06	7.43e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PRKCA—melanoma	1.55e-06	7.42e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—melanoma	1.55e-06	7.41e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—melanoma	1.55e-06	7.41e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—melanoma	1.55e-06	7.41e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—melanoma	1.55e-06	7.39e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—melanoma	1.55e-06	7.39e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—melanoma	1.55e-06	7.38e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—melanoma	1.54e-06	7.37e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—melanoma	1.54e-06	7.37e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—melanoma	1.54e-06	7.37e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—melanoma	1.54e-06	7.37e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ERCC2—melanoma	1.54e-06	7.36e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—melanoma	1.54e-06	7.35e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—melanoma	1.54e-06	7.35e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—melanoma	1.54e-06	7.34e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—melanoma	1.54e-06	7.34e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—melanoma	1.54e-06	7.33e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—melanoma	1.53e-06	7.29e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—melanoma	1.52e-06	7.28e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—melanoma	1.52e-06	7.27e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—melanoma	1.52e-06	7.27e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—melanoma	1.52e-06	7.27e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—melanoma	1.52e-06	7.27e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—melanoma	1.52e-06	7.26e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—melanoma	1.51e-06	7.23e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK3—melanoma	1.51e-06	7.21e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—melanoma	1.51e-06	7.2e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—melanoma	1.51e-06	7.2e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—melanoma	1.5e-06	7.17e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—melanoma	1.5e-06	7.17e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—melanoma	1.49e-06	7.13e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK3—melanoma	1.49e-06	7.1e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK3—melanoma	1.48e-06	7.08e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—melanoma	1.48e-06	7.06e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK3—melanoma	1.48e-06	7.06e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK3—melanoma	1.47e-06	7.04e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—melanoma	1.47e-06	7.03e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—melanoma	1.47e-06	7.02e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK3—melanoma	1.46e-06	6.97e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—melanoma	1.46e-06	6.96e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK3—melanoma	1.46e-06	6.95e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—melanoma	1.46e-06	6.95e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—melanoma	1.45e-06	6.9e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—melanoma	1.44e-06	6.89e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—melanoma	1.44e-06	6.89e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—melanoma	1.44e-06	6.89e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—melanoma	1.44e-06	6.87e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK1—melanoma	1.44e-06	6.86e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—melanoma	1.44e-06	6.86e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—melanoma	1.43e-06	6.84e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—melanoma	1.43e-06	6.83e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—melanoma	1.43e-06	6.81e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—melanoma	1.42e-06	6.78e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—melanoma	1.42e-06	6.78e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—melanoma	1.42e-06	6.76e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—melanoma	1.42e-06	6.76e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—melanoma	1.42e-06	6.76e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—melanoma	1.42e-06	6.76e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK1—melanoma	1.41e-06	6.75e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—melanoma	1.41e-06	6.75e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—melanoma	1.41e-06	6.75e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—melanoma	1.41e-06	6.75e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—melanoma	1.41e-06	6.74e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK1—melanoma	1.41e-06	6.74e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—melanoma	1.41e-06	6.74e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK1—melanoma	1.41e-06	6.72e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—melanoma	1.41e-06	6.72e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK1—melanoma	1.4e-06	6.7e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—melanoma	1.4e-06	6.69e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—melanoma	1.4e-06	6.69e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK1—melanoma	1.39e-06	6.63e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—melanoma	1.39e-06	6.63e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—melanoma	1.39e-06	6.62e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK1—melanoma	1.38e-06	6.61e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—melanoma	1.38e-06	6.61e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—melanoma	1.37e-06	6.56e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—melanoma	1.37e-06	6.54e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—melanoma	1.37e-06	6.53e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—melanoma	1.36e-06	6.48e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—melanoma	1.35e-06	6.46e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK3—melanoma	1.35e-06	6.46e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—melanoma	1.34e-06	6.42e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—melanoma	1.34e-06	6.4e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—melanoma	1.34e-06	6.38e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—melanoma	1.34e-06	6.38e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—melanoma	1.33e-06	6.36e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—melanoma	1.33e-06	6.36e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—melanoma	1.33e-06	6.36e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—melanoma	1.33e-06	6.34e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—melanoma	1.32e-06	6.32e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—melanoma	1.32e-06	6.28e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—melanoma	1.31e-06	6.28e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—melanoma	1.31e-06	6.26e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—melanoma	1.31e-06	6.25e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—melanoma	1.31e-06	6.25e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—melanoma	1.31e-06	6.24e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—melanoma	1.31e-06	6.24e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK1—melanoma	1.29e-06	6.14e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—melanoma	1.29e-06	6.14e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—melanoma	1.26e-06	6.01e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—melanoma	1.25e-06	5.98e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—melanoma	1.25e-06	5.98e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—melanoma	1.25e-06	5.98e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—melanoma	1.25e-06	5.96e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—melanoma	1.23e-06	5.89e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—melanoma	1.23e-06	5.86e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—melanoma	1.23e-06	5.85e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—melanoma	1.22e-06	5.85e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—melanoma	1.22e-06	5.84e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—melanoma	1.22e-06	5.84e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—melanoma	1.22e-06	5.83e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—melanoma	1.22e-06	5.81e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—melanoma	1.22e-06	5.81e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—melanoma	1.22e-06	5.8e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—melanoma	1.21e-06	5.77e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—melanoma	1.21e-06	5.76e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.21e-06	5.75e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.2e-06	5.74e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—melanoma	1.2e-06	5.72e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—melanoma	1.2e-06	5.72e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—melanoma	1.19e-06	5.68e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—melanoma	1.19e-06	5.67e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—melanoma	1.18e-06	5.66e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—melanoma	1.18e-06	5.64e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—melanoma	1.18e-06	5.62e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—melanoma	1.18e-06	5.61e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—melanoma	1.17e-06	5.57e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—melanoma	1.16e-06	5.55e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—melanoma	1.16e-06	5.54e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—melanoma	1.15e-06	5.51e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—melanoma	1.15e-06	5.51e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—melanoma	1.14e-06	5.42e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—melanoma	1.13e-06	5.41e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—melanoma	1.13e-06	5.39e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—melanoma	1.13e-06	5.38e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—melanoma	1.12e-06	5.33e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—melanoma	1.11e-06	5.32e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—melanoma	1.11e-06	5.31e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—melanoma	1.11e-06	5.28e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—melanoma	1.1e-06	5.27e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—melanoma	1.09e-06	5.21e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—melanoma	1.09e-06	5.19e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—melanoma	1.08e-06	5.18e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—melanoma	1.08e-06	5.16e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—melanoma	1.08e-06	5.16e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—melanoma	1.08e-06	5.14e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—melanoma	1.07e-06	5.11e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—melanoma	1.07e-06	5.09e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—melanoma	1.06e-06	5.08e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—melanoma	1.06e-06	5.06e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—melanoma	1.06e-06	5.05e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—melanoma	1.05e-06	5.03e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—melanoma	1.04e-06	4.99e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—melanoma	1.03e-06	4.93e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—melanoma	1.02e-06	4.88e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—melanoma	1.02e-06	4.86e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—melanoma	1e-06	4.79e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—melanoma	1e-06	4.78e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—melanoma	1e-06	4.78e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—melanoma	1e-06	4.77e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—melanoma	9.97e-07	4.76e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—melanoma	9.94e-07	4.75e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—melanoma	9.89e-07	4.72e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—melanoma	9.84e-07	4.7e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—melanoma	9.82e-07	4.69e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—melanoma	9.46e-07	4.52e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—melanoma	9.33e-07	4.46e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—melanoma	9.25e-07	4.41e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—melanoma	9.23e-07	4.41e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—melanoma	9.12e-07	4.35e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—melanoma	8.7e-07	4.15e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—melanoma	8.66e-07	4.13e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—melanoma	8.63e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—melanoma	8.61e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—melanoma	8.06e-07	3.85e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—melanoma	7.73e-07	3.69e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—melanoma	7.54e-07	3.6e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—melanoma	7.37e-07	3.52e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—melanoma	7.11e-07	3.39e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—melanoma	7.05e-07	3.36e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—melanoma	6.02e-07	2.88e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—melanoma	5.69e-07	2.72e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—melanoma	4.65e-07	2.22e-06	CbGpPWpGaD
